相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Post-mortem analyses of PiB and flutemetamol in diffuse and cored amyloid-β plaques in Alzheimer's disease
Milos D. Ikonomovic et al.
ACTA NEUROPATHOLOGICA (2020)
Dissection of synaptic pathways through the CSF biomarkers for predicting Alzheimer disease
Marion Tible et al.
NEUROLOGY (2020)
The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer's disease
Hlin Kvartsberg et al.
ACTA NEUROPATHOLOGICA (2019)
Pyroglutamation of amyloid-x-42 (Ax-42) followed by A1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology
Wojciech Michno et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Identification of neurotoxic cross-linked amyloid-β dimers in the Alzheimer's brain
Gunnar Brinkmalm et al.
BRAIN (2019)
A distinct brain beta amyloid signature in cerebral amyloid angiopathy compared to Alzheimer's disease
Eleni Gkanatsiou et al.
NEUROSCIENCE LETTERS (2019)
Engineered antibodies: new possibilities for brain PET?
Dag Sehlin et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
SNAP-25 isoforms differentially regulate synaptic transmission and long-term synaptic plasticity at central synapses
Muhammad Irfan et al.
SCIENTIFIC REPORTS (2019)
Staging β-Amyloid Pathology With Amyloid Positron Emission Tomography
Niklas Mattsson et al.
JAMA NEUROLOGY (2019)
Synaptotagmin 1 clamps synaptic vesicle fusion in mammalian neurons independent of complexin
Nicholas A. Courtney et al.
NATURE COMMUNICATIONS (2019)
High detection sensitivity with antibody-based PET radioligand for amyloid beta in brain
Xiaotian T. Fang et al.
NEUROIMAGE (2019)
Synaptic dysfunction in Alzheimer's disease: Mechanisms and therapeutic strategies
Yu Chen et al.
PHARMACOLOGY & THERAPEUTICS (2019)
CSF synaptic protein concentrations are raised in those with atypical Alzheimer's disease but not frontotemporal dementia
Mica T. M. Clarke et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
Synaptic biomarkers in CSF aid in diagnosis, correlate with cognition and predict progression in MCI and Alzheimer's disease
Douglas Galasko et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2019)
The Amyloid-beta Oligomer Hypothesis: Beginning of the Third Decade
Erika N. Cline et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Presenilin-mediated cleavage of APP regulates synaptotagmin-7 and presynaptic plasticity
Gael Barthet et al.
NATURE COMMUNICATIONS (2018)
QuPath: Open source software for digital pathology image analysis
Peter Bankhead et al.
SCIENTIFIC REPORTS (2017)
Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment
Olivia A. Skrobot et al.
BRAIN (2016)
The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease
Annika Ohrfelt et al.
ALZHEIMERS RESEARCH & THERAPY (2016)
pGluAβ increases accumulation of Aβ in vivo and exacerbates its toxicity
Oyinkan Sofola-Adesakin et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2016)
RBM3 mediates structural plasticity and protective effects of cooling in neurodegeneration
Diego Peretti et al.
NATURE (2015)
Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease
Cassia R. Overk et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease
Ajeet Rijal Upadhaya et al.
BRAIN (2014)
Targeting Synaptic Pathology with a Novel Affinity Mass Spectrometry Approach
Ann Brinkmalm et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer's disease
Ann Brinkmalm et al.
MOLECULAR NEURODEGENERATION (2014)
Synaptotagmin Interaction with SNAP-25 Governs Vesicle Docking, Priming, and Fusion Triggering
Ralf Mohrmann et al.
JOURNAL OF NEUROSCIENCE (2013)
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
Clifford R. Jack et al.
LANCET NEUROLOGY (2013)
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach
Thomas J. Montine et al.
ACTA NEUROPATHOLOGICA (2012)
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
Bradley T. Hyman et al.
ALZHEIMERS & DEMENTIA (2012)
An online nano-LC-ESI-FTICR-MS method for comprehensive characterization of endogenous fragments from amyloid β and amyloid precursor protein in human and cat cerebrospinal fluid
Gunnar Brinkmalm et al.
JOURNAL OF MASS SPECTROMETRY (2012)
Neurotoxicity of Amyloid β-Protein: Synaptic and Network Dysfunction
Lennart Mucke et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Identification of Novel α-Synuclein Isoforms in Human Brain Tissue by using an Online NanoLC-ESI-FTICR-MS Method
Annika Ohrfelt et al.
NEUROCHEMICAL RESEARCH (2011)
Sporadic cerebral amyloid angiopathy
J. Attems et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2011)
Cognition and beta-amyloid in preclinical Alzheimer's disease: Data from the AIBL study
Kerryn E. Pike et al.
NEUROPSYCHOLOGIA (2011)
The CERAD Neuropsychologic Battery Total Score and the Progression of Alzheimer Disease
Heidi C. Rossetti et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2010)
Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies
Tamas Revesz et al.
ACTA NEUROPATHOLOGICA (2009)
Characterization of amyloid ß peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry
Erik Portelius et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Aβ42 is more rigid than Aβ40 at the C terminus:: Implications for Aβ aggregation and toxicity
Yilin Yan et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Decreased neprilysin immunoreactivity in Alzheimer disease, but not in pathological aging
DS Wang et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2005)
Differential loss of synaptic proteins in Alzheimer's disease: Implications for synaptic dysfunction
PH Reddy et al.
JOURNAL OF ALZHEIMERS DISEASE (2005)
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
DR Thal et al.
NEUROLOGY (2002)
Synaptotagmins form a hierarchy of exocytotic Ca2+ sensors with distinct Ca2+ affinities
S Sugita et al.
EMBO JOURNAL (2002)
Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment
ST DeKosky et al.
ANNALS OF NEUROLOGY (2002)
分享论文
